Article info

Download PDFPDF

Extended report
Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

Authors

  1. Correspondence to Professor Philip J Mease; pmease{at}philipmease.com
View Full Text

Citation

Mease P, Deodhar A, Fleischmann R, et al
Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

Publication history

  • Received April 17, 2015
  • Revision received June 1, 2015
  • Accepted June 7, 2015
  • First published June 25, 2015.
Online issue publication 
June 25, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.